---
schema_version: "secwatch.filing_event.v1"
accession: "0001551306-23-000093"
form_type: "8-K"
ticker: "PGNY"
cik: "0001551306"
company_name: "Progyny, Inc."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T15:04:06.834541+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Progyny Q3 rev $280.9M (+37% YoY), net income $15.9M; raises FY guidance

## Summary
- Record quarterly revenue $280.9M, up 37% YoY; net income $15.9M ($0.16 diluted EPS).
- Adjusted EBITDA $50.0M (+43% YoY), margin 17.8% vs 17.0% prior year.
- Added 1.3M new covered lives in selling season; clients at 392 vs 282 a year ago; ~100% retention.
- Raised FY 2023 revenue guidance to $1,087-1,095M and Adj. EBITDA to $186-188.5M.
- First federal government plan win with ~300k covered lives; expects lower margin from this population in 2024.

## SEC filing metadata
- accession: 0001551306-23-000093
- form_type: 8-K
- ticker: PGNY
- cik: 0001551306
- company_name: Progyny, Inc.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551306/000155130623000093/0001551306-23-000093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551306/000155130623000093/pgny-20231107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001551306-23-000093
- JSON: https://secwatch.observer/filing/0001551306-23-000093.json
- Plain text: https://secwatch.observer/filing/0001551306-23-000093.txt

## Key facts
- Earnings Releases
  Progyny, Inc. reported three-month period ended September 30, 2023 results: revenue $280,891, net income $15,898, EPS $0.16. Guidance raised.
  - Period: three-month period ended September 30, 2023
  - Revenue: $280,891
  - Net income: $15,898
  - EPS: $0.16
  - Guidance: raised
  - Result: reported results
  source text: said Mark Livingston, Progyny’s Chief Financial Officer. Third Quarter 2023 Highlights: (unaudited; in thousands, except per share amounts) 3Q 2023 3Q 2022 Revenue $280,891 $205,371 Gross Profit $62,624 $45,995 Gross Margin 22.3% 22.4% Net Income $15,898 $13,211 Net Income per Diluted Share 1 $0.16 $0.13 Adjusted EBITDA 2 $50,019 $34,957 Adjusted
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551306/000155130623000093/0001551306-23-000093-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.